Hemodynamic, antiischemic, and neurohumoral effects of enoximone in patients with coronary artery disease

This publication has 17 references indexed in Scilit:

• A dose-response study of intravenous enoximone in congestive heart failure
  The American Journal of Cardiology, 1987
• Inotropic effect of enoximone in patients with severe heart failure: Demonstration by left ventricular end-systolic pressure-volume analysis
  Journal of the American College of Cardiology, 1987
• Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure
  American Heart Journal, 1985
• Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
  Journal of Clinical Investigation, 1985
• Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients
  Journal of the American College of Cardiology, 1984
• Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.
  Heart, 1984
• Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance
  The American Journal of Cardiology, 1984
• Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure
  New England Journal of Medicine, 1983
• The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
  Circulation, 1983
• Hemodynamic Assessment of Amrinone
  New England Journal of Medicine, 1978